Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Publication year range
1.
Int J Clin Lab Res ; 29(3): 122-7, 1999.
Article in English | MEDLINE | ID: mdl-10592110

ABSTRACT

Nitric oxide produced by an inducible nitric oxide synthase constitutes one of the main microbicidal mechanisms of murine macrophages and its importance is now being recognized for human macrophages. In this study we evaluated inducible nitric oxide synthase expression, nitric oxide release, and parasitocidal ability of Leishmania infantum-infected monocyte-derived human macrophages. The inducible nitric oxide synthase was detected by immunofluorescence and western blotting and nitric oxide production was measured by the Griess reaction for nitrites. Parasite killing was microscopically evaluated by fluorescent dyes. Experiments were performed on macrophages with or without previous stimulation with recombinant human interferon-gamma and bacterial lipopolysaccharide. Inducible nitric oxide synthase expression and nitric oxide release were higher in Leishmania-infected stimulated macrophages than in uninfected cells or infected cells without previous stimulation. Nitric oxide production and parasitocidal activity against Leishmania infantum were reduced in macrophages treated with the nitric oxide synthase inhibitor L-N(G) monomethylarginine. These results suggest a microbicidal role for nitric oxide in human leishmaniasis, with the possible practical application of immunological or pharmacological regulation of nitric oxide synthesis in the treatment of this infection.


Subject(s)
Leishmania infantum/pathogenicity , Macrophages/metabolism , Macrophages/parasitology , Nitric Oxide Synthase/metabolism , Nitric Oxide/biosynthesis , Animals , Humans , In Vitro Techniques , Interferon-gamma/pharmacology , Leishmania infantum/immunology , Lipopolysaccharides/pharmacology , Macrophage Activation , Macrophages/drug effects , Nitric Oxide Synthase Type II , Recombinant Proteins
2.
Oncogene ; 17(18): 2333-7, 1998 Nov 05.
Article in English | MEDLINE | ID: mdl-9811464

ABSTRACT

Most solid tumors are unable to grow in the ascites form, unless selected by prolonged serial transfer of peritoneal fluid (Klein, 1955). Established ascites tumor cells grow under highly crowded, virtually anoxic conditions (Warburg and Hiepler, 1953). Hypoxia was recently identified as a powerful inducer of p53 dependent apoptosis (Graeber et al., 1996). We wished to examine whether the conversion of relatively well-vascularized solid mouse tumors into freely growing ascitic cell variants favors cell with mutated or deleted p53. We have sequenced exons 4-9 of p53 cDNA from two serially transplanted methylcholanthrene induced sarcomas (MCIM and MSWBS) that were available in the original solid and the gradually converted ascites form. We have also examined five additional solid tumors, four carcinomas and one sarcoma and six additional ascites tumors, five carcinomas and one sarcoma. Sequence analysis showed that all solid tumors carried exclusively wild type p53. Among the eight ascites tumors, five carried mutant p53 and three had only the wild type gene. In one of the two isogenic pairs, the original solid tumor line had only wild type, whereas the derived ascites line had only mutant p53. In the second pair, the solid tumor was wild type whereas the ascitic variant was heterozygous. The naturally occurring alternatively spliced p53 (p53as) mRNA was detected in all solid tumors, but not in five of the eight ascites tumors. Our findings indicate that conversion of solid into ascites tumors favors the selection of cell variants with mutated p53 and of cells that lack the alternatively spliced form of p53.


Subject(s)
Ascites/genetics , Ascites/pathology , Cell Hypoxia , Genes, p53/genetics , Mutation/genetics , Neoplasms, Experimental/genetics , Neoplasms, Experimental/pathology , Tumor Suppressor Protein p53/metabolism , Animals , Gene Deletion , Mammary Neoplasms, Experimental/genetics , Mammary Neoplasms, Experimental/pathology , Mice , Mice, Inbred C3H , Mice, Inbred C57BL , Sarcoma, Experimental/genetics , Sarcoma, Experimental/pathology , Tumor Cells, Cultured
3.
Immunopharmacol Immunotoxicol ; 18(3): 355-74, 1996 Aug.
Article in English | MEDLINE | ID: mdl-8872490

ABSTRACT

The immunological effects of interferon (IFN)-alpha administration were evaluated in 15 patients with cHCV infection. Individuals were treated with 6 MU of lymphoblastoid IFN-alpha three times a week for 6 months and with 3 MU three times a week for an additional 6 months. Patients were divided into responders (12 subjects) and nonresponders (3 subjects), respectively, according to alanine aminotransferase serum levels at the end of treatment. Before therapy (T0), absolute numbers of CD3+, CD4+, CD8+, CD14+ and CD16+ cells were significantly reduced in both groups when compared to normal values. At the same time, all patients displayed a profound decrease of phagocytosis and killing exerted by both polymorphonuclear cells (PMN) and monocytes (MO). However, MO Killing resulted to be normal in the responder group. With special reference to T cell function, T cell mediated antibacterial activity, using Salmonella typhi as a target, was also significantly reduced. After therapy (T12), in responder patients a significant increase of CD3+, CD4+, CD14+ and CD16+ cell absolute numbers was observed, while phagocytic and T cell functions were still depressed. Among the nonresponders, in two of three patients IFN-alpha administration gave rise to an increase (above normality) of CD3+, CD4+, CD8+, CD14+, CD16+ and CD20+ cell absolute numbers, while in one patient the same markers dramatically dropped below normal range. In two patients, antibacterial activity was significantly augmented by IFN-alpha treatment, whereas in one patient no modification was observed. Finally, in the same patients IFN-alpha did not correct PMN and MO pretreatment deficits.


Subject(s)
Hepatitis C/immunology , Hepatitis C/therapy , Hepatitis, Chronic/immunology , Hepatitis, Chronic/therapy , Interferon-alpha/immunology , Interferon-alpha/therapeutic use , Adult , Aged , Female , Hepacivirus/drug effects , Humans , Immunization, Passive , Leukocytes, Mononuclear/drug effects , Macrophages/drug effects , Male , Middle Aged , Neutrophils/drug effects , Phagocytosis/drug effects
4.
Immunopharmacol Immunotoxicol ; 17(2): 347-64, 1995 May.
Article in English | MEDLINE | ID: mdl-7650295

ABSTRACT

In 54 patients with cHCV infection, peripheral immune responsiveness and soluble mediator release were evaluated. Results demonstrate that in these patients phagocytosis and killing capacities exerted by polymorphonuclear cells and monocytes were profoundly depressed. At the same time, absolute numbers of CD3+, CD8+ and CD16+ cells were reduced, while the CD4(+)-CD8+ dependent antibacterial activity was also impaired. With special reference to soluble mediators, elevated amounts of both soluble interleukin-2 receptor and soluble intercellular adhesion molecule-1 were detected in sera of patients. By contrast, serum levels of tumor necrosis factor-alpha were within normal ranges, whereas interferon-gamma serum concentrations were decreased. Of note, in 18.5% of cHCV patients circulating levels of bacterial lipopolysaccharides (LPS) were detected by means of Limulus assay. In the Limulus+subset of patients, absolute numbers of CD14+ cells were reduced in a significant manner, this implying a putative monocyte-LPS interaction. In conclusion, the overall results indicate a condition of peripheral immune depression in cHCV patients with an exaggerated shedding of various mediators endowed with noxious effects for the host.


Subject(s)
Cytokines/immunology , Hepatitis C/immunology , Immunity, Cellular/immunology , Adult , Aged , Chronic Disease , Cytokines/analysis , Female , Humans , Immune Tolerance , Intercellular Adhesion Molecule-1/analysis , Male , Middle Aged , Monocytes/immunology , Neutrophils/immunology , Phagocytosis/immunology , Receptors, Interleukin-2/analysis , T-Lymphocytes/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...